Association between apolipoprotein E4 genotype and human immunodeficiency virus–associated dementia in younger adults starting antiretroviral therapy in South Africa

References

• An SF, Giometto B, Groves M, Miller RF, Beckett AA, Gray F, Tavolato B, Scaravilli F (1997). Axonal damage revealed by accumulation of beta-APP in HIV-positive individuals without AIDS. J Neuropathol Exp Neurol 56: 1262–1268.
   PubMed Web of Science ®Google Scholar
• Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789–1799.
   PubMed Web of Science ®Google Scholar
• Barger SW, Harmon AD (1997). Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388: 878–881.
   PubMed Web of Science ®Google Scholar
• Burt TD, Agan BK, Marconi VC, He W, Kulkarni H, Mold JE, Cavrois M, Huang Y, Mahley RW, Dolan MJ, McCune JM, Ahuja SK (2008). Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Proc Natl Acad Sci U S A 105: 8718–8723.
   PubMed Web of Science ®Google Scholar
• Colton CA, Needham LK, Brown C, Cook D, Rasheed K, Burke JR, Strittmatter WJ, Schmechel DE, Vitek MP (2004). APOE genotype-specific differences in human and mouse macrophage nitric oxide production. J Neuroimmunol 147: 62–67.
   PubMed Web of Science ®Google Scholar
• Corder EH, Paganelli R, Giunta S, Franceschi C (2008). Differential course of HIV-1 infection and APOE polymorphism. Proc Natl Acad Sci U S A 105: E87.
   PubMed Web of Science ®Google Scholar
• Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, Hall C (1998). HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 4: 1182–1184.
   PubMed Web of Science ®Google Scholar
• Department of Health (2008). South Africa National HIV and Syphilis Prevalence Survey. Pretoria, South Africa: Department of Health.
   Google Scholar
• Dunlop O, Goplen AK, Liestol K, Myrvang B, Rootwelt H, Christophersen B, Kvittingen EA, Maehlen J (1997). HIV dementia and apolipoprotein E. Acta Neurol Scand 95: 315–318.
   PubMed Web of Science ®Google Scholar
• Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC (2002c). Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 155: 487–495.
   PubMed Web of Science ®Google Scholar
• Esiri MM, Biddolph SC, Morris CS (1998). Prevalence of Alzheimer plaques in AIDS. J Neurol Neurosurg Psychiatry 65: 29–33.
   PubMed Web of Science ®Google Scholar
• Fernhaber C, Reyneke A, Schulze D, Malope B, Maskew M, Macphail P, Sanne I, Di Biscleglie A (2008). The prevalence of hepatitis B co-infection in a South African urban government HIV clinic. S Afr Med J 98: 541–544.
   PubMed Web of Science ®Google Scholar
• Frisoni GB, Geroldi C, Bianchetti A, Trabucchi M, Govoni S, Franceschini G, Calabresi L (1994). Apolipoprotein E epsilon 4 allele frequency in vascular dementia and Alzheimer's disease. Stroke 25: 1703–1704.
   PubMed Web of Science ®Google Scholar
• Gerdes LU (2003). The common polymorphism of apolipoprotein E: geographical aspects and new pathophysiological relations. Clin Chem Lab Med 41: 628–631.
   PubMed Web of Science ®Google Scholar
• Gupta JD, Satishchandra P, Gopukumar K, Wilkie F, Waldrop-Valverde D, Ellis R, Ownby R, Subbakrishna D. K, Desai A, Kamat A, Ravi V, Rao BS, Satish KS, Kumar M (2007). Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J. NeuroVirol 13: 195–202.
   PubMed Web of Science ®Google Scholar
• Hixson JE. Vernier, DT (1990). Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545–548.
   PubMed Web of Science ®Google Scholar
• Jacobs GB, Loxton AG, Laten A, Robson B, van Rensburg EJ, Engelbrecht S (2009). Emergence and diversity of different HIV-1 subtypes in South Africa, 2000–2001. J Med Virol 81: 1852–1859.
   PubMed Web of Science ®Google Scholar
• Joska JA, Fincham DS, Stein DJ, Paul RH, Seedat S (2009). Clinical correlates of HIV-associated neurocognitive disorders in South Africa. AIDS Behav 14(2):371–378.
   PubMed Web of Science ®Google Scholar
• Joska JA, Westgarth-Taylor J, Myer L, Hoare J, Thomas KG, Combrinck M, Paul RH, Stein DJ, Flisher AJ (2010). Characterization of HIV-associated neurocognitive disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Kamboh MI, Sepehrnia B, Ferrell RE (1989). Genetic studies of human apolipoproteins. VI. Common polymorphism of apolipoprotein E in blacks. Dis Markers 7: 49–55.
   PubMed Web of Science ®Google Scholar
• Kaslow RA, Dorak T, Tang JJ (2005). Influence of host genetic variation on susceptibility to HIV type 1 infection. J Infect Dis 191(Suppl 1):S68–S77.
   PubMedGoogle Scholar
• Laws SM, Hone E, Gandy S, Martins RN (2003). Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem 84: 1215–1236.
   PubMed Web of Science ®Google Scholar
• Mahley RW, Weisgraber KH, Huang Y (2009). Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS. J Lipid Res 50(Suppl):S183–S188.
   PubMedGoogle Scholar
• Mayo O (2008). A century of Hardy-Weinberg equilibrium. Twin Res Hum Genet 11: 249–256.
   PubMed Web of Science ®Google Scholar
• Mishra M, Vetrivel S, Siddappa N. B, Ranga U, Seth P (2008). Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif. Ann Neurol 63: 366–376.
   PubMed Web of Science ®Google Scholar
• Pemberton LA, Stone E, Price P, van BF, Brew BJ (2008). The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementia. HIV Med 9: 677–680.
   PubMed Web of Science ®Google Scholar
• Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinisto L, Halonen P, Kontula K (1995). Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med 333: 1242–1247.
   PubMed Web of Science ®Google Scholar
• Samatovicz RA (2000). Genetics and brain injury: apolipoprotein E. J Head Trauma Rehabil 15: 869–874.
   PubMed Web of Science ®Google Scholar
• Sandholzer C, Delport R, Vermaak H, Utermann G (1995). High frequency of the apo epsilon 4 allele in Khoi San from South Africa. Hum Genet 95: 46–48.
   PubMed Web of Science ®Google Scholar
• Valcour V, Shikuma C, Shiramizu B, Watters M, Poff P, Selnes OA, Grove J, Liu Y, bdul-Majid KB, Gartner S, Sacktor N (2004). Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort. J Neuroimmunol 157: 197–202.
   PubMed Web of Science ®Google Scholar
• Valcour V, Shiramizu B, Shikuma C (2008). Frequency of apolipoprotein E4 among older compared with younger HIV patients: support for detrimental effect of E4 on survival. Proc Natl Acad Sci U S A 105: E66–E68.
   PubMedGoogle Scholar